Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...
Q3 2025 Earnings Call Transcript November 4, 2025 Leidos Holdings, Inc. beats earnings expectations. Reported EPS is $3.05, ...
Data from our ABC News Data team reveals just how many people within the greater Houston area typically receive SNAP benefits ...